Chikungunya virus is an Alphavirus that has been causing large scale outbreaks in the Americas since 2013. Clinical symptoms including high fever, rash, headache, vomiting, myalgia, and severe joint pain.
At The Native Antigen Company we offer a wide range of Chikungunya antigens and antibodies to support IVD assay development and vaccine R&D. These include mammalian expressed recombinant Virus-like particles, soluble envelope proteins, cell receptor proteins and neutralising monoclonal antibodies.
Chikungunya virus (CHIKV) is a member of the genus Alphavirus in the family Togaviridae. Chikungunya fever is a mosquito-borne disease first identified in Tanzania in 1953. Since 2004 there have been extensive outbreaks in Africa and Asia, and in 2013 the first cases were identified in the Caribbean, and by September 2014 more than 650,000 cases had been reported in the Americas. Chikungunya fever usually starts 2–4 days after CHIKV infection, with clinical symptoms including high fever, rash, headache, vomiting, myalgia, and severe joint pain.
Because the virus is transmitted by the same mosquitos that transmit Dengue Virus and Zika Virus, and the clinical symptoms of infection with the viruses are also similar, it is important to be able to distinguish diagnostically between the different infections.
We offer a range of recombinant antigens for Chikungunya virus studies, all prepared using our proprietary mammalian cell expression system. These include our unique Virus-like particles (containing E1, E2 and Capsid proteins), together with soluble E1 and E2 envelope proteins.
The most recent addition to our Chikungunya range is a recombinant MXRA8 protein, which has been shown to be a cell surface receptor mediating viral entry into host cells
Our range of antibodies specific for Chikungunya virus includes monoclonal antibodies binding Capsid protein and to E2 envelope protein. We also offer a polyclonal antibody raised against our Chikungunya Virus-like particles, which binds to Capsid, E1 and E2 proteins.
Check out our FAQ section for answers to the most frequently asked questions about our website and company.